Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carta

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2022
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's DiseaseMaria Francesca Palmas, Anna Ena, Chiara Burgaletto, et al.
Journal of Biomedical Science|June 16, 2025
Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegenerationShih Chang Hsueh, Pathik Parekh, Buyandelger Batsaikhan, et al.
EMBO Molecular Medicine|October 4, 2023
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2Marzia Indrigo, Ilaria Morella, Daniel Orellana, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 24, 2022
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's DiseaseMaria Francesca Palmas, Anna Ena, Chiara Burgaletto, et al.
Journal of Biomedical Science|June 16, 2025
Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegenerationShih Chang Hsueh, Pathik Parekh, Buyandelger Batsaikhan, et al.
EMBO Molecular Medicine|October 4, 2023
Nuclear ERK1/2 signaling potentiation enhances neuroprotection and cognition via Importinα1/KPNA2Marzia Indrigo, Ilaria Morella, Daniel Orellana, et al.
Pageof 9